Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Mats Remberger

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Living Beings

Concepts & Ideas

Phenomena

Recurrence

Chemicals & Drugs

HLA Antigens

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
93
Ringdén, Olle
51
Mattsson, Jonas
38
Ljungman, Per
36
Aschan, Johan
23
Barkholt, Lisbeth
22
Hägglund, Hans
20
Svahn, Britt-Marie
16
Uzunel, Mehmet
16
Lönnqvist, B
14
Carlens, S
14
Winiarski, Jacek
13
Hentschke, Patrik
12
Le Blanc, Katarina
11
Omazic, Brigitta
10
Klaesson, S

Sign-in to see all Coauthors

Publications

TOP 3
Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Le Blanc Katarina; Barrett A John; Schaffer Marie; Hägglund Hans; Ljungman Per; Ringdén Olle; Remberger Mats
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.
Remberger Mats; Sundberg Berit
Low serum levels of total rabbit-IgG is associated with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation: results from a prospective study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mats Remberger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(5):393-9.
2009: Le Blanc Katarina; Barrett A John; Schaffer Marie; Hägglund Hans; Ljungman Per; Ringdén Olle; Remberger Mats
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1108-15.
2009: Remberger Mats; Sundberg Berit
Low serum levels of total rabbit-IgG is associated with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation: results from a prospective study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(8):996-9.
2008: Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström A-C; Remberger M
Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Tissue antigens 2008;72(6):549-58.
2008: Ringdén O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor.
Bone marrow transplantation 2008;42(10):643-8.
2008: Sairafi D; Uzunel M; Remberger M; Ringdén O; Mattsson J
No impact of NOD2/CARD15 on outcome after SCT.
Bone marrow transplantation 2008;41(11):961-4.
2008: Le Blanc Katarina; Frassoni Francesco; Ball Lynne; Locatelli Franco; Roelofs Helene; Lewis Ian; Lanino Edoardo; Sundberg Berit; Bernardo Maria Ester; Remberger Mats; Dini Giorgio; Egeler R Maarten; Bacigalupo Andrea; Fibbe Willem; Ringdén Olle;
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.
Lancet 2008;371(9624):1579-86.
2008: Remberger Mats; Mattsson Jonas; Hausenberger Dan; Schaffer Marie; Svahn Britt-Marie; Ringdén Olle
Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemia.
European journal of haematology 2008;80(5):419-28.
2008: Barkholt L; Remberger M; Hassan Z; Fransson K; Omazic B; Svahn B-M; Karlsson H; Brune M; Hassan M; Mattsson J; Ringdén O
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2008;41(9):785-90.
2008: Svahn Britt-Marie; Remberger Mats; Heijbel Mona; Martell Eva; Wikström Marie; Eriksson Britta; Milovsavljevic Ruza; Mattsson Jonas; Ringdén Olle
Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition.
Transplantation 2008;85(7):1000-7.
2008: Giraud G; Priftakis P; Bogdanovic G; Remberger M; Dubrulle M; Hau A; Gutmark R; Mattson J; Svahn B-M; Ringden O; Winiarski J; Ljungman P; Dalianis T
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts.
Bone marrow transplantation 2008;41(8):737-42.
2008: Conrad Réka; Remberger Mats; Cederlund Kerstin; Ringdén Olle; Barkholt Lisbeth
A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
Haematologica 2008;93(2):265-72.
2008: Norlin A-C; Sairafi D; Mattsson J; Ljungman P; Ringdén O; Remberger M
Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival.
Bone marrow transplantation 2008;41(3):267-73.
2008: Remberger M; Mattsson J; Hassan Z; Karlsson N; LeBlanc K; Omazic B; Okas M; Sairafi D; Ringdén O
Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.
Bone marrow transplantation 2008;41(4):399-405.
2007: Bjorklund A; Aschan J; Labopin M; Remberger M; Ringden O; Winiarski J; Ljungman P
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation.
Bone marrow transplantation 2007;40(11):1055-62.
2007: Barkholt L; Remberger M; Bodegård H; Ringdén O; Böttiger Y
Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Bone marrow transplantation 2007;40(7):683-9.
2007: Hassan Zuzana; Remberger Mats; Svenberg Petter; Elbander Maria; Omazic Brigitta; Mattsson Jonas; Conrad Réka; Svahn Britt-Marie; Ahlgren Anders; Sairafi Darius; Aschan Johan; Le Blanc Katarina; Barkholt Lisbeth; Ringdén Olle
Hemorrhagic cystitis: a retrospective single-center survey.
Clinical transplantation 2007;21(5):659-67.
2007: Remberger Mats; Ringdén Olle
Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
Transplantation 2007;84(4):551-4.
2007: Le Blanc K; Samuelsson H; Gustafsson B; Remberger M; Sundberg B; Arvidson J; Ljungman P; Lönnies H; Nava S; Ringdén O
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(8):1733-8.
2007: Ringdén O; Remberger M; Svenberg P; Svahn B-M; Dahllöf G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Bone marrow transplantation 2007;39(7):383-8.
2006: Mattsson J; Westin S; Edlund S; Remberger M
Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease.
Bone marrow transplantation 2006;38(9):629-33.
2006: Uzunel Mehmet; Remberger Mats; Sairafi Darius; Hassan Zuzana; Mattsson Jonas; Omazic Brigitta; Barkholt Lisbeth; Ringdén Olle
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
Transplantation 2006;82(7):913-9.
2006: Sundin Mikael; Le Blanc Katarina; Ringdén Olle; Barkholt Lisbeth; Omazic Brigitta; Lergin Christina; Levitsky Victor; Remberger Mats
The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
Haematologica 2006;91(8):1059-67.
2006: Ringdén O; Svenberg P; Le Blanc K; Mattsson J; Remberger M
Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases.
Bone marrow transplantation 2006;38(4):321-2.
2006: Svahn Britt-Marie; Alvin Ole; Ringdén Olle; Gardulf Ann; Remberger Mats
Costs of allogeneic hematopoietic stem cell transplantation.
Transplantation 2006;82(2):147-53.
2006: Svahn Britt-Marie; Ringdén Olle; Remberger Mats
Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades.
Transplantation 2006;81(11):1600-3.
2006: Ringdén Olle; Uzunel Mehmet; Rasmusson Ida; Remberger Mats; Sundberg Berit; Lönnies Helena; Marschall Hanns-Ulrich; Dlugosz Aldona; Szakos Attila; Hassan Zuzana; Omazic Brigitta; Aschan Johan; Barkholt Lisbeth; Le Blanc Katarina
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
Transplantation 2006;81(10):1390-7.
2006: Ringdén Olle; Remberger Mats; Svahn Britt-Marie; Barkholt Lisbeth; Mattsson Jonas; Aschan Johan; Le Blanc Katarina; Gustafsson Britt; Hassan Zuzana; Omazic Brigitta; Svenberg Petter; Solders Göran; von Döbeln Ulrika; Winiarski Jacek; Ljungman Per; Malm Gunilla
Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center.
Transplantation 2006;81(5):718-25.
2006: Giraud Géraldine; Bogdanovic Gordana; Priftakis Peter; Remberger Mats; Svahn Britt-Marie; Barkholt Lisbeth; Ringden Olle; Winiarski Jacek; Ljungman Per; Dalianis Tina
The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen.
Haematologica 2006;91(3):401-4.
2006: Conrad Réka; Remberger Mats; Cederlund Kerstin; Hentschke Patrik; Sundberg Berit; Ringdén Olle; Barkholt Lisbeth
Inflammatory cytokines predominate in cases of tumor regression after hematopoietic stem cell transplantation for solid cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(3):346-54.
2006: Forslöw Ulrica; Mattsson Jonas; Ringden Olle; Klominek Julius; Remberger Mats
Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation.
Scandinavian journal of infectious diseases 2006;38(11-12):970-6.
2005: Svahn B M; Ringdén O; Remberger M
Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.
Bone marrow transplantation 2005;36(6):511-6.
2005: Jaksch Marie; Uzunel Mehmet; Remberger Mats; Sundberg Berit; Mattsson Jonas
Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II-IV.
Clinical transplantation 2005;19(3):346-9.
2005: Mattsson Jonas; Remberger Mats; Andersson Olof; Sundberg Berit; Nord Magnus
Decreased serum levels of clara cell secretory protein (CC16) are associated with bronchiolitis obliterans and may permit early diagnosis in patients after allogeneic stem-cell transplantation.
Transplantation 2005;79(10):1411-6.
2005: Ringdén Olle T H; Le Blanc Katarina; Remberger Mats
Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applications.
Experimental hematology 2005;33(5):505-12.
2005: Jaksch Marie; Remberger Mats; Mattsson Jonas
Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):280-7.
2005: Hentschke P; Omazic B; Mattsson J; Näsman-Björk I; Lundkvist I; Gigliotti D; Barkholt L; Ringdén O; Remberger M
T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
Scandinavian journal of immunology 2005;61(3):285-94.
2005: Remberger Mats; Beelen Dietrich W; Fauser Axel; Basara Nadezda; Basu Oliver; Ringdén Olle
Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors.
Blood 2005;105(2):548-51.
2004: Svenberg Petter; Remberger Mats; Svennilson Johan; Mattsson Jonas; Leblanc Katarina; Gustafsson Britt; Aschan Johan; Barkholt Lisbeth; Winiarski Jacek; Ljungman Per; Ringdén Olle
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):877-82.
2004: Bogdanovic G; Priftakis P; Giraud G; Kuzniar M; Ferraldeschi R; Kokhaei P; Mellstedt H; Remberger M; Ljungman P; Winiarski J; Dalianis T
Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation.
Journal of clinical microbiology 2004;42(11):5394-6.
2004: Schaffer Marie; Malmberg Karl-Johan; Ringdén Olle; Ljunggren Hans-Gustaf; Remberger Mats
Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation.
Transplantation 2004;78(7):1081-5.
2004: Le Blanc Katarina; Remberger Mats; Uzunel Mehmet; Mattsson Jonas; Barkholt Lisbeth; Ringdén Olle
A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation.
Transplantation 2004;78(7):1014-20.
2004: Barkholt Lisbeth; Danielsson Rimma; Calissendorff Bertil; Svensson Leif; Malihi Reza; Remberger Mats; Uzunel Mehmet; Thörne Anders; Ringdén Olle
Indium-111-labelled donor-lymphocyte infusion by way of hepatic artery and radio-frequency ablation against liver metastases of renal and colon carcinoma after allogeneic hematopoietic stem-cell transplantation.
Transplantation 2004;78(5):697-703.
2004: Remberger Mats; Svahn Britt-Marie; Mattsson Jonas; Ringdén Olle
Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation.
Transplantation 2004;78(1):122-7.
2004: Kiehl Michael G; Kraut Ludwig; Schwerdtfeger Rainer; Hertenstein Bernd; Remberger Mats; Kroeger Nicolaus; Stelljes Mathias; Bornhaeuser Martin; Martin Hans; Scheid Christoph; Ganser Arnold; Zander Axel R; Kienast Joachim; Ehninger Gerhard; Hoelzer Dieter; Diehl Volker; Fauser Axel A; Ringden Olle
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2816-25.
2004: Nordlander Anna; Mattsson Jonas; Ringdén Olle; Leblanc Katarina; Gustafsson Britt; Ljungman Per; Svenberg Petter; Svennilson Johan; Remberger Mats
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):195-203.
2004: Ringdén Olle; Schaffer Marie; Le Blanc Katarina; Persson Ulla; Hauzenberger Dan; Abedi Mohammad R; Olerup Olle; Ljungman Per; Remberger Mats
Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):128-34.
2004: Jaksch Marie; Remberger Mats; Mattsson Jonas
Increased immune transcript levels are correlated with acute graft-versus-host disease and cytomegalovirus response after allogeneic stem cell transplantation.
Transplantation 2004;77(2):195-200.
2003: Le Blanc Katarina; Ringdén Olle; Remberger Mats
A low body mass index is correlated with poor survival after allogeneic stem cell transplantation.
Haematologica 2003;88(9):1044-52.
2003: Schaffer M; Aldener-Cannavá A; Remberger M; Ringdén O; Olerup O
Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation.
Tissue antigens 2003;62(3):243-50.
2003: Mattsson J; Uzunel M; Remberger M; Hassan M
Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation.
Bone marrow transplantation 2003;32(5):477-83.
2003: Remberger M; Naseh N; Aschan J; Barkholt L; LeBlanc K; Svennberg P; Ringdén O
G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
Bone marrow transplantation 2003;32(2):217-23.
2003: Remberger Mats; Jaksch Marie; Uzunel Mehmet; Mattsson Jonas
Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation.
European journal of haematology 2003;70(6):384-91.
2003: Svennilson Johan; Remberger Mats; Ringdén Olle
Risk factors for moderate-to-severe acute graft-vs.-host disease after allogeneic stem cell transplantation in children.
Pediatric transplantation 2003;7(2):130-6.
2003: Jaksch M; Uzunel M; Martinez Cangana G; Remberger M; Mattsson J
Increased levels of immune transcript in patients with acute GVHD after allogeneic stem cell transplantation.
Bone marrow transplantation 2003;31(3):183-90.
2003: Hentschke P; Barkholt L; Uzunel M; Mattsson J; Wersäll P; Pisa P; Martola J; Albiin N; Wernerson A; Söderberg M; Remberger M; Thörne A; Ringdén O
Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.
Bone marrow transplantation 2003;31(4):253-61.
2002: Remberger M; Mattsson J; Hentschke P; Aschan J; Barkholt L; Svennilson J; Ljungman P; Ringdén O
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors.
Bone marrow transplantation 2002;30(11):761-8.
2002: Remberger Mats; Persson Ulla; Hauzenberger Dan; Ringdén Olle
An association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
British journal of haematology 2002;119(3):751-9.
2002: Svahn Britt-Marie; Remberger Mats; Myrbäck Karl-Erik; Holmberg Katarina; Eriksson Britta; Hentschke Patrik; Aschan Johan; Barkholt Lisbeth; Ringdén Olle
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
Blood 2002;100(13):4317-24.
2002: Ruutu Tapani; Eriksson Britta; Remes Kari; Juvonen Eeva; Volin Liisa; Remberger Mats; Parkkali Terttu; Hägglund Hans; Ringdén Olle;
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.
Blood 2002;100(6):1977-83.
2002: Hentschke Patrik; Remberger Mats; Mattsson Jonas; Barkholt Lisbeth; Aschan Johan; Ljungman Per; Ringdén Olle
Clinical tolerance after allogeneic hematopoietic stem cell transplantation: a study of influencing factors.
Transplantation 2002;73(6):930-6.
2002: Remberger M; Storer B; Ringdén O; Anasetti C
Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors.
Bone marrow transplantation 2002;29(5):391-7.
2002: Remberger Mats; Kumlien Gunilla; Aschan Johan; Barkholt Lisbeth; Hentschke Patrik; Ljungman Per; Mattsson Jonas; Svennilson Johan; Ringdén Olle
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(12):674-82.
2001: Socié G; Clift R A; Blaise D; Devergie A; Ringden O; Martin P J; Remberger M; Deeg H J; Ruutu T; Michallet M; Sullivan K M; Chevret S
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.
Blood 2001;98(13):3569-74.
2001: Uzunel M; Mattsson J; Jaksch M; Remberger M; Ringdén O
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia.
Blood 2001;98(6):1982-4.
2001: Remberger M; Ringdén O; Blau I W; Ottinger H; Kremens B; Kiehl M G; Aschan J; Beelen D W; Basara N; Kumlien G; Fauser A A; Runde V
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors.
Blood 2001;98(6):1739-45.
2001: Remberger M; Aschan J; Barkholt L; Tollemar J; Ringdén O
Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin.
Clinical transplantation 2001;15(3):147-53.
2001: Rocha V; Cornish J; Sievers E L; Filipovich A; Locatelli F; Peters C; Remberger M; Michel G; Arcese W; Dallorso S; Tiedemann K; Busca A; Chan K W; Kato S; Ortega J; Vowels M; Zander A; Souillet G; Oakill A; Woolfrey A; Pay A L; Green A; Garnier F; Ionescu I; Wernet P; Sirchia G; Rubinstein P; Chevret S; Gluckman E
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.
Blood 2001;97(10):2962-71.
2001: Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
Transplantation proceedings 2001;33(1-2):1769-70.
2001: Mattsson J; Uzunel M; Remberger M; Ringdén O
T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation.
Transplantation 2001;71(3):433-9.
2001: Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
European journal of haematology 2001;66(1):50-6.
2001: Mattsson J; Uzunel M; Remberger M; Tammik L; Omazic B; Levitsky V; Zou J Z; Hentschke P; Ringdén O
Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.
Clinical and experimental immunology 2001;123(1):162-9.
2001: Carlens S; Remberger M; Aschan J; Ringdén O
The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):31-8.
2000: Carlens S; Gilljam M; Remberger M; Aschan J; Christensson B; Dilber M S
Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution.
Experimental hematology 2000;28(10):1137-46.
2000: Ringdén O; Remberger M; Runde V; Bornhäuser M; Blau I W; Basara N; Hölig K; Beelen D W; Hägglund H; Basu O; Ehninger G; Fauser A A
Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation.
Bone marrow transplantation 2000;25 Suppl 2():S6-8.
2000: Ringdén O; Söderdahl G; Mattsson J; Uzunel M; Remberger M; Hentschke P; Hägglund H; Sparrelid E; Elmhorn-Rosenborg A; Duraj F; Zetterquist H; Ericzon B G
Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.
Transplantation 2000;69(10):2043-8.
2000: Ringdén O; Remberger M; Lehmann S; Hentschke P; Mattsson J; Klaesson S; Aschan J
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation.
Bone marrow transplantation 2000;25(9):993-6.
2000: Mattsson J; Uzunel M; Remberger M; Ljungman P; Kimby E; Ringdén O; Zetterquist H
Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(2):247-54.
2000: Björk I N; Brissac C; Remberger M; Mattsson J; Klaesson S; Ringdén O; Stewart J; Lundkvist I
Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT).
Clinical and experimental immunology 2000;119(1):240-9.
1999: Aschan J; Carlens S; Hägglund H; Klaesson S; Mattsson J; Remberger M
Improved survival after bone marrow transplantation for early leukemia using busulfan-cyclophosphamide and individualized prophylaxis against graft-versus-host disease: a long-term follow-up.
Clinical transplantation 1999;13(6):512-9.
1999: Hägglund H; Ringdén O; Oman S; Remberger M; Carlens S; Mattsson J
A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation.
Bone marrow transplantation 1999;24(8):831-6.
1999: Remberger M; Svahn B M; Hentschke P; Löfgren C; Ringdén O
Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation.
Bone marrow transplantation 1999;24(8):823-30.
1999: Carlens S; Aschan J; Remberger M; Dilber M; Ringdén O
Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia.
Bone marrow transplantation 1999;24(6):629-35.
1999: Aschan J; Remberger M; Carlens S; Mattsson J; Dilber M S; Lönnqvist B; Björkstrand B
Unrelated donor stem cell transplantation after autologous transplantation: experience of a single center.
Bone marrow transplantation 1999;24(3):279-82.
1999: Ringdén O; Remberger M; Runde V; Bornhäuser M; Blau I W; Basara N; Hölig K; Beelen D W; Hägglund H; Basu O; Ehninger G; Fauser A A
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.
Blood 1999;94(2):455-64.
1999: Ringdén O; Remberger M; Ruutu T; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Mellander L; Ljungman P; Jacobsen N
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.
Blood 1999;93(7):2196-201.
1998: Hägglund H; Remberger M; Klaesson S; Lönnqvist B; Ljungman P; Ringdén O
Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation.
Blood 1998;92(12):4568-72.
1998: Sparrelid E; Hägglund H; Remberger M; Ringdén O; Lönnqvist B; Ljungman P; Andersson J
Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection.
Bone marrow transplantation 1998;22(8):795-800.
1998: Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn B M; Winiarski J; Ljungman P; Aschan J
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Bone marrow transplantation 1998;22(8):755-61.
1998: Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn B M; Ljungman P
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.
Transplantation 1998;66(5):620-5.
1998: Hägglund H; Ringdén O; Remberger M; Lönnqvist B; Sparrelid E; Tammik L; Kumlien G
Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow.
Bone marrow transplantation 1998;22(2):131-6.
1998: Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(1):73-8.
1998: Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Clinical transplantation 1998;12(2):84-92.
1998: Hägglund H; Ringdén O; Agren B; Wennberg L; Remberger M; Rundquist L; Svahn B M; Aspelin P
Intraosseous compared to intravenous infusion of allogeneic bone marrow.
Bone marrow transplantation 1998;21(4):331-5.
1998: Söderdahl G; Tammik C; Remberger M; Ringdén O
Cadaveric bone marrow and spleen cells for transplantation.
Bone marrow transplantation 1998;21(1):79-84.
1998: Ringdén O; Remberger M; Mattsson J; Aschan J; Carlens S; Hägglund H; Lönnqvist B; Sparrelid E; Ljungman P
Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age.
Bone marrow transplantation 1998;21(1):43-9.
1997: Ringdén O; Andström E E; Remberger M; Dahllöf G; Svahn B M; Tollemar J
Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
Pediatric transplantation 1997;1(2):124-9.
1997: Carlens S; Ringdén O; Remberger M; Mattsson J; Aschan J; Hägglund H; Ljungman P
Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemia.
Transplantation proceedings 1997;29(7):3147-9.
1997: Ringdén O; Remberger M; Mattsson J; Aschan J; Hägglund H; Carlens S; Lönnqvist B; Sparrelid E; Ljungman P
Transplantation with unrelated bone marrow in leukemic patients above 40 years of age.
Transplantation proceedings 1997;29(7):3145-6.
1997: Remberger M; Ringdén O
Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver.
European journal of haematology 1997;59(4):254-62.
1997: Dahllöf G; Bågesund M; Remberger M; Ringdén O
Risk factors for salivary dysfunction in children 1 year after bone marrow transplantation.
Oral oncology 1997;33(5):327-31.
1997: Mattsson J; Ringdén O; Aschan J; Barkholt L; Dalianis T; Hägglund H; Ljungman P; Lönnqvist B; Tollemar J; Winiarski J; Remberger M
A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate.
Transplantation proceedings 1997;29(1-2):735-6.
1997: Söderdahl G; Tammik C; Remberger M; Sandberg J; Tufveson G; Tollemar J; Ringdén O
Immune markers and hematopoiesis of cadaveric bone marrow for transplantation.
Transplantation proceedings 1997;29(1-2):714-5.
1996: Andström E E; Ringdén O; Remberger M; Svahn B M; Tollemar J
Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.
Mycoses 1996;39(5-6):185-93.
1996: Winiarski J; Ringdén O; Remberger M; Dalianis T; Ljungman P; Borgström B
Bone marrow transplantation in children using unrelated donors at Huddinge Hospital.
Acta paediatrica (Oslo, Norway : 1992) 1996;85(3):327-35.
1995: Hägglund H; Boström L; Remberger M; Ljungman P; Nilsson B; Ringdén O
Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients.
Bone marrow transplantation 1995;16(6):747-53.
1995: Aschan J; Ringdén O; Ljungman P; Hägglund H; Klaesson S; Dalianis T; Remberger M
Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: the experience at Huddinge Hospital.
Transplantation proceedings 1995;27(6):3531-2.
1995: Sparrelid E; Hägglund H; Remberger M; Ljungman P; Malmborg A S; Winiarski J; Andersson J; Ringdén O
Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation.
Transplantation proceedings 1995;27(6):3530.
1995: Remberger M; Ringdén O
Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
Transplantation 1995;60(11):1293-9.
1995: Ringdén O; Remberger M; Persson U; Ljungman P; Aldener A; Andström E; Aschan J; Bolme P; Dahllöf G; Dalianis T
Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.
Bone marrow transplantation 1995;15(4):619-25.
1995: Remberger M; Ringden O; Markling L
TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.
Bone marrow transplantation 1995;15(1):99-104.
1994: Ringdén O; Remberger M; Aschan J; Lungman P; Lönnqvist B; Markling L
Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Transplantation 1994;58(8):887-91.
1994: Aschan J; Ringdén O; Andström E; Ljungman P; Lönnqvist B; Remberger M
Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.
Bone marrow transplantation 1994;14(1):79-87.
1994: Ringdén O; Remberger M; Persson U; Ljungman P; Aschan J; Bolme P; Dahllöf G; Dalianis T; Gahrton G; Lönnqvist B
[New facts about bone marrow transplantation. An unrelated donor is as good as a related one]
Läkartidningen 1994;91(26-27):2577-82.
1994: Ringdén O; Ruutu T; Remberger M; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Ljungman P
A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies.
Transplantation proceedings 1994;26(3):1831-2.
1994: Remberger M; Ringden O; Aschan J; Ljungman P; Lönnqvist B; Markling L
Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Transplantation proceedings 1994;26(3):1829-30.
1994: Aschan J; Ringdén O; Andström E; Ljungman P; Remberger M
Prevention of graft-versus-host disease on an individual basis.
Transplantation proceedings 1994;26(3):1823-4.
1994: Hägglund H; Boström L; Ringdén O; Nilsson B; Remberger M
Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.
Transplantation proceedings 1994;26(3):1821-2.
1994: Ringdén O; Ruutu T; Remberger M; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Ljungman P
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group.
Blood 1994;83(9):2723-30.
1994: Ringdén O; Andström E; Remberger M; Svahn B M; Tollemar J
Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin.
Bone marrow transplantation 1994;14 Suppl 5():S10-4.
1993: Klaesson S; Ringdén O; Markling L; Remberger M; Lundkvist I
Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro.
Scandinavian journal of immunology 1993;38(5):477-84.

Sign-in to see more